MRNA - Moderna Inc.

Momentum play to downside; if it breaks under $59.30, expect downtrend to continue.

Healthcare has led the second half of the year in 6 of the last midterm years, and healthcare is leading in June. Identified as a solid company.

FDA advisory committee voted 9-0 in favor of benefit-risk profile for investigational seasonal influenza vaccine. Stock ripped 12.5% on Friday, held gains well, and broke above recent resistance. Strong uptrend since beginning of year. Healthcare sector tailwinds in midterm year back half.

MRNA popped 11.5% on news that the FDA advisory committee will meet June 18th to discuss approval of its mRNA-based flu vaccine. The stock is breaking past recent highs around $60. Hosts like the momentum and news catalyst.

Closed up over 7% today. Watching for a break above the double-top around $49.56 for an upside opportunity.

Momentum play to the downside. Fell 4% today. Watch for continuation lower if it breaks below $48.20.

Had a great move up ~16%; if it can break above $60 resistance, watch for further upside continuation

No direct mention, but a placeholder. Not in transcript.

Healthcare stock to the downside. If it falls below $45, watch it to the downside. Could not sustain opening levels.

Up 15%+ today in a massive momentum move. If it breaks the high of day around $53.25, further upside is expected. Described as 'insane' momentum.